L. Sehn, M. Chamuleau, G. Lenz, M. Clausen, C. Haioun, K. Izutsu, A. Davies, Jun Zhu, T. Oki, E. Szafer-Glusman, R. Conlon, Hueiyu Chiou, D. Ipe, B. Elliott, Jun Wu, G. Salles
{"title":"皮下依可利他单抗+ R-CHOP与单独R-CHOP治疗新诊断弥漫性大b细胞淋巴瘤(DLBCL)的ABCL-517 III期试验:EPCORE DLBCL-2","authors":"L. Sehn, M. Chamuleau, G. Lenz, M. Clausen, C. Haioun, K. Izutsu, A. Davies, Jun Zhu, T. Oki, E. Szafer-Glusman, R. Conlon, Hueiyu Chiou, D. Ipe, B. Elliott, Jun Wu, G. Salles","doi":"10.1016/s2152-2650(23)01333-2","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ABCL-517 Phase III Trial of Subcutaneous Epcoritamab + R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2\",\"authors\":\"L. Sehn, M. Chamuleau, G. Lenz, M. Clausen, C. Haioun, K. Izutsu, A. Davies, Jun Zhu, T. Oki, E. Szafer-Glusman, R. Conlon, Hueiyu Chiou, D. Ipe, B. Elliott, Jun Wu, G. Salles\",\"doi\":\"10.1016/s2152-2650(23)01333-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10370,\"journal\":{\"name\":\"Clinical Lymphoma Myeloma and Leukemia\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma Myeloma and Leukemia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s2152-2650(23)01333-2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2152-2650(23)01333-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
ABCL-517 Phase III Trial of Subcutaneous Epcoritamab + R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2